| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4007473 | Archivos de la Sociedad Española de Oftalmología | 2013 | 7 Pages |
Abstract
After ranibizumab treatment, age-related macular degeneration patients with accompanying vitreomacular traction showed a tendency to have a poorer prognosis in terms of visual acuity than patients without this finding. In addition, higher numbers of intravitreal injections were required to obtain clinical responses in patients with vitreomacular traction.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
A. Filloy, L. Arias,